Apolipoproteins and Lipoproteins in Health and Disease 2.0

Noemi Rotllan; Joan Carles Escolà-Gil

doi:10.3390/ijms25116183

Apolipoproteins and Lipoproteins in Health and Disease 2.0

Int J Mol Sci. 2024 Jun 4;25(11):6183. doi: 10.3390/ijms25116183.

Authors

Noemi Rotllan^{1

2}, Joan Carles Escolà-Gil^{1

2}

Affiliations

¹ Institut de Recerca Sant Pau, 08041 Barcelona, Spain.
² CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 28029 Madrid, Spain.

Abstract

Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, accounting for 32% of global deaths, according to the World Health Organization (WHO) [...].

Publication types

Editorial
Introductory Journal Article

MeSH terms

Apolipoproteins* / metabolism
Cardiovascular Diseases* / metabolism
Humans
Lipoproteins* / metabolism

Substances

Apolipoproteins
Lipoproteins

Grants and funding

This work was funded by Ministerio de Ciencia, Innovación y Universidades as well as from the Agencia Estatal de Investigación (AEI/10.13039/501100011033) within the Subprograma Ramón y Cajal (RYC-201722879) to N.R. CIBERDEM is an Instituto de Salud Carlos III project.